Abstract
How has the Covid-19 pandemic affected mental health? What are the most common positives and negatives? How do population variables mediate the impact on mood and behaviour? Who is most at risk of adverse consequences? Which pragmatic measures can help? We address these questions in a data-driven manner by applying multivariate, machine-learning and natural-language processing methods to a survey database collected from 376,987 members of the general public. We report that small average changes in mood from pre-to mid-pandemic obfuscate substantial consequences, both positive and negative, for people from particular sub-populations, vocations, circumstances and personality profiles. The coping strategies that people find helpful during the pandemic are correspondingly diverse yet predictable. We propose that by combining psychological, and demographic variables, it is possible to identify individuals who are at most risk of adverse consequences and to extract individually tailored advice from the collective lived experiences of the general population.
Competing Interest Statement
Disclosures: Dr. Chamberlain consults for Promentis, and receives stipends for journal editorial work from Elsevier. Dr. Grant has received research grants from the TLC Foundation for Body-Focused Repetitive Behaviors, Biohaven, Promentis, and Avanir Pharmaceuticals. Prof. Mehta has received grant income from Takeda Pharmaceuticals, Johnson & Johnson and Lundbeck.
Clinical Trial
This was a large scale observational study run in collaboration with BBC2 Horizon. It was not a clinical trial.
Funding Statement
Dr Hampshire is supported by the UK Dementia Research Institute and Biomedical Research Centre at Imperial College London with technology development supported by EU-CIG EC Marie‐Curie CIG and NIHR grant II-LB-0715-20006. Dr Soreq's role was supported by MRC grant MR/R005370/1. William Trender is supported by the EPSRC Center for Doctoral Training in Neurotechnology. Dr Chamberlain's role in this study was funded by a Wellcome Trust Clinical Fellowship (Reference 110049/Z/15/Z). Mitul Mehta is in part supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. We would like to acknowledge COST Action CA16207 'European Network for Problematic Usage of the Internet', supported by COST (European Cooperation in Science and Technology); and the support of the National UK Research Network for Behavioural Addictions (NUK-BA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Imperial College Research Ethics Committee. 17IC4009 ICREC
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Extended analyses have been added in this revision.
Data Availability
Summary data for this cohort are provided in the supplementary appendices.
